share_log
Breakings ·  Jul 26 20:36
ProMIS Neurosciences: Results Demonstrated Favorable Safety Profile and Tolerability Across Four Ascending Dose Levels in Healthy Volunteers
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment